Physician profile
Chad E Smith
NPI 1851549455
$14,779.33
in general payments reported to CMS, 2019-2025
19 companies · $922 in 2025
The $922 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,793 · 2020: $1,809 · 2021: $1,291 · 2022: $3,292 · 2023: $2,620 · 2024: $52.17 · 2025: $922.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,468 · Food and Beverage: $1,126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,467.81 |
| Food and Beverage | $1,126.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Orthopedic Systems | $10,029.30 | 2019-2023 | |
| Arthrex, INC. | $2,429.26 | 2019-2023 | |
| Zimmer Biomet Holdings, INC. | $735.04 | 2019-2025 | Persona, Oxford, Tapestry |
| Blue Surgical LLC | $644.81 | 2024-2025 | |
| Linkbio Corp | $241.44 | 2022 | |
| Stryker Corporation | $182.27 | 2019-2021 | |
| Horizon Therapeutics Plc | $145.46 | 2019-2020 | |
| Medical Device Business Services, INC. | $99.99 | 2022 | |
| Smith+Nephew, INC. | $52.71 | 2019-2022 | |
| Restor3d, INC. | $47.04 | 2023 | |
| Sanara Medtech INC. | $31.56 | 2023 | Celleraterx |
| Pacira Therapeutics, INC. | $29.52 | 2019 | |
| Bioventus LLC | $29.24 | 2019 | |
| Orthofix Medical, INC. | $20.07 | 2022 | |
| Dompe US, INC. | $15.34 | 2025 | Oxervate |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $15.01 | 2025 | |
| Ferring Pharmaceuticals INC. | $14.68 | 2019 | |
| Bone Support INC. | $14.03 | 2025 | Ceramentbone Void Filler, Cerament G |
| Orthosensor INC. | $2.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.